1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Venezuela Pharmaceuticals and Healthcare Report Q4 2015

Venezuela Pharmaceuticals and Healthcare Report Q4 2015

  • September 2015
  • -
  • Business Monitor International
  • -
  • 109 pages

Includes 3 FREE quarterly updates

BMI View: The Venezuelan government remains committed to its optimistic outlook despite growingpolitical tension and growing volatility within the country's economy. This clash will keep Venezuela'sinflationary pressures on a soaring trajectory, as pharmaceutical and health market expenditure growth inreal terms remain negative despite the bolivar continuing to grow. Drugmakers and health companies willcontinue to experience severely negative exchange rates, compounded by an increasingly unstable countryoutlook, hampering investment and revenue-generating opportunities for years to come.

Headline Expenditure Projections

- Pharmaceuticals: VEB51.0bn (USD8.1bn) in 2014 to VEB63.1bn (USD2.2bn) in 2015; +23.7% in localcurrency terms and -73.4% in US dollar terms. Forecast has been revised downward from Q315 due toupdated macroeconomic considerations, reflecting real market growth.

Table Of Contents

Venezuela Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Venezuela 2011-2019) 17
Healthcare Market Forecast 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2011-2019) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2011-2019) 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2011-2019) 20
Prescription Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019) 26
OTC Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Venezuela 2013-2019) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Venezuela 2013-2019) 32
Key Risks To BMI's Forecast Scenario 33
Macroeconomic Forecasts 34
Economic Analysis 34
Table: Venezuela - Private Consumption Forecasts 35
Table: Venezuela - Government Consumption Forecasts 36
Table: Venezuela - Fixed Investment Forecasts 36
Table: Venezuela - Net Exports Forecasts 38
Industry Risk Reward Indices 39
Americas Risk/Reward Index - Q4 2015 39
Venezuela Risk/Reward Index 45
Rewards 45
Risks 45
Market Overview 47
Industry Trends And Developments 48
Epidemiology 48
Healthcare Sector 50
Table: Healthcare Resources (Venezuela 2009-2014) 53
Table: Healthcare Personnel (Venezuela 2009-2014) 53
Table: Healthcare Activity (Venezuela 2009-2014) 54
Research And Development 56
Regulatory Development 59
Intellectual Property 59
Biologics And Biosimilars 63
Pricing Regime 63
Reimbursement Regime 65
Competitive Landscape 66
Research-Based Industry 66
Generic Drugmakers 68
Pharmaceutical Distribution 68
Pharmaceutical Retail Sector 70
Company Profile 72
Boehringer Ingelheim 72
Calox International 74
Elmor 76
GlaxoSmithKline 79
Grupo Farma 82
Merck and Co 85
Novartis 88
Pfizer 91
Sanofi 94
Strides Latina (Sumifarma) 96
Demographic Forecast 98
Demographic Outlook 2015 98
Table: Population Headline Indicators (Venezuela 1990-2025) 99
Table: Key Population Ratios (Venezuela 1990-2025) 99
Table: Urban/Rural Population and Life Expectancy (Venezuela 1990-2025) 100
Table: Population By Age Group (Venezuela 1990-2025) 100
Table: Population By Age Group % (Venezuela 1990-2025) 101
Glossary 103
Methodology 105
Pharmaceutical Expenditure Forecast Model 105
Healthcare Expenditure Forecast Model 105
Notes On Methodology 106
Risk/Reward Index Methodology 107
Index Overview 108
Table: Pharmaceutical Risk/Reward Index Indicators 108
Indicator Weightings 109

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.